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Injection of day-12 murine fetal liver cells into thymus lobes of Thy-1 congenic adult
recipients results in a wave of thymocyte development. The kinetics of repopulation by
donor cells reaches a peak after 20-25 days. The frequency of thymic stem cells (TSC) in
day-12 fetal liver was estimated, by limit dilution, as 1 in 4x104 cells. Within 8 hr of
injection into a thymus lobe, fetal liver TSC commit to T-cell development, losing stem-cell
activity. When fetal liver cells are maintained in culture for 7 days, with no exogenous
cytokines added, and then injected intra-thymically (I.T.), thymus recolonization is not
observed. However, TSC can be maintained in culture for 7 days with IL-1]/, IL-3, IL-6, or
LIF added, alone or in combination, with steel factor (SLF). Poisson analysis of fetal liver
cells cultured with SLF and IL-3 together revealed a precursor frequency of 1 in 1.8x 105
cells. In contrast, the frequency of TSC in adult bone marrow was estimated by limit
dilution as 1 in 12,000 cells.
KEYWORDS: Thymus, stem cells, fetal liver, cytokines.
INTRODUCTION
Thymus stem cells (TSC) are functionally defined
here as those cells that have the capacity to seed the
thymus and differentiate to functional thymus-
derived (T) lymphocytes. Hematopoietic stem cells
isolated from mouse fetal liver or bone marrow have
been reported to express low levels of Thy-1 antigen
(Thy-11w), the Sca-1 antigen, but not the lineage
markers Gr-1, Mac-l, B220, CD4, and CD8 (Lin-),
and it has been estimated that these cells represent
0.05-0.1% of the total population (Spangrude et al.,
1988a; 1988b; Ikuta et al., 1990). Thy-1
lw Sca-1
lin- cells have the capacity to form day-12 spleen
colonies (CFU-S) when injected intravenously into
lethally irradiated adult mice, and to differentiate
into T lymphocytes when injected into adult thymic
lobes (Spangrude et al., 1988b). The earliest thymo-
cyte progenitor population found in adult thymus
appears to express low levels of the CD4 antigen
(Wu et al., 1991).
A number of growth factors including Steel factor
(SLF) (Huang et al., 1990; Williams et al., 1990;
Zsebo et al., 1990), leukemia inhibitory factor (LIF)
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(Williams et al., 1988; Fletcher et al., 1990; 1991),
interleukin-3 and-6 (Bodine et al., 1989; Chervenak
and Altazan, 1990), and interleukin-7 (Namen et al.,
1988; Watson et al., 1989) have been reported as
having an effect on stem cells or early progenitor cell
survival. Many of these are produced by stromal
cells of the bone marrow. The production of cytok-
ines by the stromal cells of fetal liver that may
influence haemotopoietic stem cells has not been
well documented. SLF exists in a membrane an-
chored and soluble form, is the ligand for the
ci-kit proto-oncogene, and is the gene product of the
murine Steel locus on chromosome 10 (Huang et al.,
1990; Williams et al., 1990; Zsebo et al., 1990). The
hematologic phenotype of mice with mutations of
the Steel locus is characterized by a reduced number
of hematopoietic stem cells, macrocytic anaemia,
and a reduction of tissue mast cells (Russell, 1979).
A normal number of both T and B lymphocytes is
found in the peripheral lymphoid organs of Steel
mice (Russell, 1979). SLF synergizes with IL-7 to
enhance the growth of pre-B colonies in semisolid
cultures of murine bone marrow (McNiece et al.,
1991). SLF by itself stimulates the proliferation of
bone marrow-derived murine spleen colony-
forming cells (CFU-S) in vitro and shows synergy in
combination with IL-1 and IL-3 (de Vries et al.,
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1991). Most in vitro clonogenic cells of the bone
marrow as well as CFU-S express c-kit. The excep-
tion are the in vivo colony-forming cells responsive
to IL-7 (Ogawa et al., 1991). A population of
primitive stem cells that do not express c-kit, but
give rise to c-kit
/ cells in vitro have been described
(Kodama et al., 1992). Anti c-kit antibody treatment
severely depleted bone marrow cultures of the cells
that give rise to day-12 CFU-S. The cultures recov-
ered to pretreatment CFU-S levels on return to
normal growth conditions.
We show here that cells from day-12 unfraction-
ated murine fetal liver repopulate the thymic lobes
of irradiated adult mice with distinctive kinetics
expected of TSC. A limiting dilution analysis of this
colonization event has been performed. Using adop-
tive transfer to secondary recipients, we have stud-
ied the loss of stem-cell activity of these cells upon
entry to the thymic environment. We conclude that
commitment to the T-cell lineage is rapid, occuring
within a few hours, and as a result of this, the ability
to transfer stem-cell activity is lost. TSC in day-12
fetal liver can be maintained in vitro for 7 days
provided the culture is supplemented with IL-1,8,
IL-3, IL-6, or LIF in both the presence and absence
of SLF. A limit dilution analysis of TSC in fetal liver
after 1 week in culture with SLF and IL-3 revealed
this cytokine combination had not induced a net
increase in the number of TSC.
RESULTS
Kinetics of Thymus Lobe Reconstitution
The following experiments establish the criteria we
use to characterize TSC and are similar to studies
reported elsewhere (Goldschneider et al., 1986;
Scollay et al., 1986; Spangrude et al., 1988b). The
effect of whole-body sublethal irradiation (750 rads)
on adult thymocyte numbers was examined and a
loss of more than 95% of thymocytes occurred over
3 days from each thymic lobe. After 5 days, thymo-
cyte numbers began to increase and reached a
plateau level of approximately 2-4x107 cells per
lobe on day 12. This effect has been reported by a
number of people (Takada et al., 1969; reviewed
Anderson and Warner, 1976; Hirokawa et al., 1985;
Mulder et al., 1985) and was observed whether or
not the thymus had been intra-thymically (I.T.)
injected with donor cells.
To follow the kinetics of the recolonization pro-
cess using the expression of the Thy-1 marker, a
single-cell suspension was prepared from day-12
embryonic liver of C57BL/Thy1.2 mice. Groups of
6-8-week-old C57BL/Thy1.1 mice were irradiated
(750 rads) and after 3 hours, 5x10s cells were
injected into one thymus lobe of each recipient. The
second thymus lobe served as a control. Coloniza-
tion of this lobe by donor cells was rarely seen,
confirming observations that TSC show very limited
migration from the lobe they are injected into
(Goldschneider et at., 1986; Scollay et al., 1986).
Beginning at day 8 after transfer, and continuing
until day 30, C57BL/Thy1.1 recipients were sacri-
ficed, and control and injected lobes separately
removed and analyzed for the presence of Thyl.1
and Thyl.2
/ cells. The data presented in Fig. 1 are
a summary of the percentage of both Thyl.1
/ and
Thyl.2
/ cells found in the injected lobes of individ-
ual recipients. From day 10 and continuing to
around day 22, there occurred a steady increase in
Thyl.2
/ cells, with a concomitant loss of Thyl.1
/
cells, until they consistently comprised greater than
90% of the Thyl cells. At this point, mature
donor-derived T cells were readily detectable in
both spleen and lymph nodes (data not presented).
This pattern of reconstitution was similar for fetal
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FIGURE 1. The kinetics of appearance of donor-derived Thy-
cells after intra-thymic transfer of fetal liver cells. 5 x 105 fetal
liver cells prepared from C57BL/Thy1.2 mice were injected intra-
thymically into one thymic lobe of sublethally irradiated adult
C57BL/Thyl.1 mice. On designated days, the mice were sacri-
ficed, both thymic lobes were removed, and the percentage of
Thyl.1 cells and Thyl.2 cells determined. The data represent
an example of three experiments performed using cells from
day-12 embryos.THYMUS STEM CELLS 249
liver cells from day-11 and-13 embryos (data not
presented).
Effect of Cell Numbers on Thymus Lobe
Reconstitution
Groups of adult C57BL/Thy1.1 mice were irradi-
ated (750 rads) and 3 hours later injected I.T. in one
thymus lobe with a limiting number of day-12 fetal
liver cells. The number of donor cells ranged from
3.13 x 103 per lobe. Twenty-one days after injection,
thymus lobes were harvested and the proportion of
Thyl.1 and Thyl.2 cells determined. A wide
range in the proportion of donor-derived cells was
seen in each group, and this was independent of the
number of cells injected. The lowest level observed
was just 3% repopulation in a mouse in the group
that received 2.5 x 104 cells. Any lobe that contained
a minimum of 1% donor cells was scored positive
for colonization. The findings have been presented
in Figs. 2(A) and 2(B). When subjected to a Poisson
analysis, the data followed single-hit kinetics. For
each point plotted, between 20 and 33 mice were
analyzed. The interpretation of these results is that
a single cell is capable of recolonizing a thymus lobe,
and that the frequency of TSC in day-12 fetal liver
is around 1 in 4 x 104 cells.
Loss of Reconstitution Potential of Thymus
Stem Cells
As stem cells differentiate in the thymus, they
appear to lose their thymic recolonization potential
(reviewed by Scollay et al., 1988). The kinetics by
which stem cells lost their ability to colonize the
thymus was analyzed. A group of C57BL/Thy1.1
adult mice was irradiated (750 rads) and 3 hours
later injected I.T. in one thymus lobe with I x 10
6
liver cells from day-12 C57BL/Thy1.2 embryos.
After 1, 8, 24, 48, and 96 hours, mice from this
group were sacrificed, the injected lobes harvested,
and single-cell suspensions prepared. A second
group of adult C57BL/Thy1.1 mice was irradiated
(750 rads) and one thymus lobe of each injected
with up to 5 x 106 cells from the cell suspensions.
Although it was impossible to quantitate accurately
the number of donor-derived cells in each group, we
estimated that the 5 x 106 cells would contain suffi-
cent numbers of fetal liver cells or their progeny to
reconstitute an adult thymus lobe if the cells re-
tained their original reconstitution ability. The re-
sults of a typical experiment are presented in Fig. 3.
At days 12, 15, and 20, Thyl.2 cells were detected
in thymus lobes injected directly with I x 106 fresh
day-12 fetal liver cells or with 5 x 106 thymocytes
prepared 1 hour after the first I.T. injection. This
also served as a control, demonstrating that fetal
liver cells diluted by injection into an adult thymus
lobe could be detected by secondary transfer. No
significant numbers of Thyl.2
/ cells were detected
in thymus lobes when donor cells prepared 8, 24, or
48 hr after the first I.T. injection were transferred
into secondary recipients.
Survival of Thymic Stem Cells in Culture
Numbers of cytokines were examined for their
ability to support fetal liver TSC in culture. When
day-12 fetal liver cells were cultured in medium
supplemented separately with 20 ng/ml of IL-I,
IL-3, IL-6, IL-7, or LIF, minimal proliferation was
observed (as with cultures with no cytokines added).
SLF, however, induced significant proliferation over
7 days, resulting in cell numbers approximately
five-fold above those obtained with medium alone.
This SLF-induced increase was further augmented
with the addition of any of the five cytokines (Fig.
4). Interestingly, morphological differences were ev-
ident in these cultures. In cultures containing no
cytokines along with those supplemented with
IL-1]/, IL-3, IL-6, IL-7, or LIF, monolayers of adher-
ent stromal type cells grew with clusters of closely
attached, rounded, non adherent cells. In cultures
containing SLF (either alone or in conjunction with
another cytokine), the outgrowth of the adherent
stromal layer was markedly inhibited. When cells
were harvested 5 to 7 days after culture without
cytokines added, and injected I.T., repopulation as
reflected by a wave of appearance of donor Thyl.2
thymocytes was not observed. Up to 3-5x10s
viable cells recovered from cell cultures were rou-
tinely injected in these experiments. SLF and IL-7
alone or in conjunction with SLF also failed to
maintain the TSC in culture for 7 days. However,
when 3x105 cells from 7-day cultures supple-
mented with IL-1,8, IL-3, IL-6, or LIF, alone or in
addition to SLF, were injected I.T., donor-derived
thymocytes were detected 21 days after injection,
suggesting that these conditions had all acted to
maintain stem-cell viability (data not shown). Fetal
liver cells grown in a combination of SLF and IL-3
were subjected to a limit dilution assay to determine
whether these culture conditions had induced TSC
proliferation. At day 21, the mice were sacrificed250 McKENNA et at.
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FIGURE 2. (A) The effect of limiting cell numbers on thymic lobe reconstitution. Sublethally irradiated C57BL/Thyl.1 adult mice
were intra-thymically injected with limiting numbers of day-12 C57BL/Thy1.2 fetal liver cells, ranging from 5 X 104 down to 3.13 x 103
cells. Twenty-one days after injection the mice were sacrificed and the proportion of Thyl.1 and Thyl.2 cells was determined in
the injected lobe. Any lobe showing greater than 1% Thyl.2 cells at day 21 was scored as showing repopulation. (The solid square
represents one mouse, and the fractions to the right denote the number of mice showing repopulation relative to the number injected.)
(B) Poisson analysis of the limit dilution data. The fraction of non-repopulated mice from Fig. 2(A) was plotted against the number
of cells injected (solid triangles). Poisson analysis of limit dilution performed with SLF + IL-3 cultured fetal liver: Day- 12 fetal liver
cells from C57BL/Thy1.2 embryos were isolated and placed in culture supplemented with SLF + IL-3 as for Fig. 4. After 7 days, the
cells were harvested and the viable cells counted. The increase in net cell number was noted. Numbers ranging from 1.7x 105 down
to 2.08x104 were injected I.T. and the mice were sacrificed and analyzed on day 21. Fifty-seven mice were analyzed. The fraction
of nonrepopulated mice were plotted against the number of cells injected (open circle). (The solid square is the frequency of TSC in
adult bone marrow. Each group contained 20 mice.)THYMUS STEM CELLS 251
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FIGURE 3. The loss of reconstitution potential of thymic stem
cells. C57BL/Thy1.1 adult mice were sublethally irradiated and 3
hr later were injected I.T. with lx106 day-12 C57BL/Thy1.2
fetal liver cells. At designated times (1, 8, 24, and 48 hr after this
primary injection), the mice were sacrificed and the injected lobes
were removed. A single-cell suspension was made and 5 x 10
viable thymocytes were transferred I.T. into secondary suble-
thally irradiated C57BL/Thy1.1 adults. The percent of Thyl.2
thymocytes was determined 12, 15, and 20 days after this
secondary transfer. The control group received only the primary
injection.
and the thymic lobes assayed; see Fig. 2(B). The
frequency of TSC as determined by Poisson analysis
had fallen to 1 in 1.8x 105 cells. As there was a
three- to fourfold increase in total cell numbers over
the 7 days in culture, we conclude that the combi-
nation of SLF and IL-3 had maintained the viability
of the TSC, but there had been no significant net
increase in TSC number.
Frequency of Thymus Stem cells in Adult
Bone Marrow
To determine the frequency of TSC in adult bone
marrow, groups of 20 adult C57BL/Thy1.1 mice
were irradiated (750 rads) and injected with Thy 1.2
adult bone marrow cells. The number of donor cells
ranged from 2 x 103 to 8 x 104 per lobe. Twenty-one
days after injection, thymus lobes were harvested
and the proportion of Thyl.1
+ and Thyl.2
+ cells
determined. The results have also been included in
Fig. 2(B). Unlike the results using fetal liver as donor
cells, the lowest level of repopulation was 30%
Thyl.2 cells in a mouse that had received 5 x 103
cells. When subjected to a Poisson analysis, the data
followed single-hit kinetics with the frequency of
TSC around 1 in 12,000 cells.
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FIGURE 4. Proliferative response of
day-12 fetal liver to cytokines and the
detection of thymic reconstitution by
cytokine grown cells. Day-12 C57BL/
Thyl.2 fetal liver was removed and a
single-cell suspension was prepared.
Cells were plated in 24-well plates at
5 x 105 viable cells per milliliter. The
designated cytokines were all added
at 20-30 ng/ml. The medium was
replaced 5 days after establishing the
cultures, and on day 7, the cultures
were harvested and the number of
viable cells determined. Each figure
plotted represents the mean of 7-10
wells. Sublethally irradiated C57BL/
Thyl.1 adults (6-10 per group) were
injected I.T. with 3-5 x 105 viable cells
from each culture condition. The per-
cent of donor-derived Thyl.2 cells
was determined on day 21. The
groups with mice showing repopula-
tion are marked with an asterisk(’).252 McKENNA et al.
DISCUSSION
The strategy used here to identify cells with thymic
stem-cell activity has been the colonization of a
sublethally irradiated adult thymus lobe following
direct injection of donor cells (Goldschneider et al.,
1986; Scollay et al., 1986; Spangrude et al., 1988b).
Injection of 5 x 105 day-11 to -13 fetal liver cells
from Thyl.2 donors into Thyl.1 recipients results in
a lag period of some 8-10 days during which donor
cells are virtually undetectable in thymus lobes (Fig.
1). The donor cells contain no Thy-1high cells (data
not shown). A similar lag period has been observed
after injection of adult bone marrow I.V. and I.T.
(Boersma et al., 1981; Scollay et al., 1986; Gold-
schneider et al., 1986; Mulder et al., 1985), and fetal
liver I.V. (Boersma, 1983). Between day 10 and 12,
Thyl.2
/ cells begin to accumulate, and increase
until day 20-25, when mature T cells begin to exit
the thymus lobe. As these cells exit, a wave of
thymocytes of host origin replace them. This kinetic
pattern has been used by others to define stem cells
with the property of thymic reconstitution (Gold-
schneider et al., 1986; Scollay et al., 1986; Span-
grude et al., 1988b; Ikuta et al., 1990). The number
of stem cells that seed the thymus under these
conditions is likely to be small. After I.T. transfer of
200-7000 bone marrow-derived stem cells, Span-
grude and Scollay (1990) noted an earlier appear-
ance of donor Thy-1 cells that quickly reached a
plateau by day 16-17. The delayed appearance of
thymocytes expressing high levels of Thy-1 antigen
appears to represent a period of proliferation. Dur-
ing ontogeny, the first thymic stem cells initiate
colonization of the fetal thymus around day 11 of
gestation, and mature into Thy-1
/ cells without the
10-day lag period seen in adult thymus colonization
(Jotereau et al., 1987), suggesting that either fetal
and adult thymic stem cells differ or the environ-
ments in to which they seed differ.
We have attempted to estimate the frequency of
TSC in unfractionated fetal liver by limit dilution.
Decreasing numbers of fetal liver cells were injected
into thymic lobes of groups of irradiated adult
recipients. When examined 21 days after injection,
the proportion of donor-derived Thy-1 cells in
each recipient varied widely; see Fig. 2(A). This
effect appeared independent of the number of fetal
liver cells initially injected. There are several possi-
ble explanations for this. Firstly, when a limited
number of cells was injected, host-derived bone
marrow stem cells that survived irradiation also seed
the thymus, thus creating a chimeric lobe. Secondly,
some form of competition may exist between host-
and donor-derived TSC, not evident when a rela-
tively large number of donor cells are injected (Fig.
1). Thirdly, TSC may be a heterogenous population.
Some have the capacity to give rise to large numbers
of progeny, whereas others yield a much smaller
clone size. Finally, as more cells seed in the thymus,
an environment for furthur seeding of TSC may be
created that, in the case of limited availability of
donor-type stem cells, would mean that host-
derived TSC cells would be favored.
By scoring lobes that contained a minimum 1%
donor-type cells as positive, single-hit kinetics were
observed. Poisson analysis yielded an estimate of 1
in 4x 104, or 0.0025% for TSC; see Fig. 2(B). This is
lower than estimates of stem cells in adult bone
marrow or day-14 fetal liver (Katsura et al., 1986;
Spangrude et al., 1988b; Ikuta et al., 1990). As a
result, we then analyzed TSC in adult bone marrow
using limit dilution and observed a frequency of
1:12,000; see Fig. 2(B). Thus, there is a real differ-
ence in the frequencies of TSC in fetal liver and
adult bone marrow. Boersma (1983) has demon-
strated that the frequency of both prothymocytes
and day-9 CFU-S in fetal liver is considerably less
than that in bone marrow. This effect was reported
after I.V. transfer and may reflect a poorer homing
ability rather than a lower frequency and fetal liver
TSC may not seed the adult thymus as efficiently as
TSC in adult bone marrow. The difference between
the estimates of 1 in 12,000 for TSC frequency in
bone marrow and I in 41,000 for fetal liver might be
explained purely by the different source of these
TSC, the fact that these estimates were made on
different days post-I.T, injection, or the level of
detection of Thy-1 cells. The estimates of the
frequency in day-14 fetal liver; 1 in 14,000 by Ikuta
et al. (1900) and 1 in 6,000 (the number required to
give 50% of the mice repopulated) by Katsura et al.
(1986) are difficult to compare. It is unclear at what
time point Ikuta et al. (1990) analyzed their mice.
Katsura et al. (1986) analyzed their mice 21 days
post-I.T. It has been demonstrated that early fetal
liver is primarily involved in the production of cells
of the erythroid lineage (Metcalf and Moore, 1971).
Stem cells present in the liver, at or around day 12,
may favor commitment to cells of the erythroid/
myeloid lineage, thus limiting the proportion of
stem cells available for the T-cell lineage.
It has been reported that colonization of a thymic
lobe can result from the seeding of very few cells.THYMUS STEM CELLS 253
Wallis et al. (1975) demonstrated that an irradiated
thymus could be entirely repopulated with few stem
cells after intra-venous (I.V.) transfer of bone mar-
row cells. The same conclusion was reached by
Ezine et al. (1984). In some mice they observed total
lobe repopulation resulted from just one cell. Injec-
tion of 5 x 104 fetal liver cells resulted in 70% of the
thymus lobes showing repopulation at day 21; see
Fig. 2(A). This observation supports the observations
of Wallis et al. (1975) and Ezine et al. (1984).
Recently, de Vries et al. (1992) reported that thymic
repopulation was observed in four out of nine mice
that had been injected I.T. with just one c-kit cell
purified from adult bone marrow.
The loss of the reconstitution capacity of TSC was
followed by a secondary adoptive transfer proce-
dure (Fig. 3). The interesting observation was that
after fetal liver cells had been in the thymus for 8 hr,
their ability to recolonize another thymus lobe was
lost. We argue from these data that following entry
to the thymus, these cells rapidly undergo differen-
tiation events that commit them to the T-cell lineage
(even though Thy-1 cells cannot be detected for 10
days) with a concomitant loss of stem-cell activity.
We have observed a similar phenomenon using
adult bone marrow or c-kit cells (de Vries et al.,
1992) purified from adult bone marrow (unpub-
lished data). In an adult thymus, TSC activity
contained within the most recent immigrants, the
CD41w/CD8- cells and the double negatives
(CD4-/CD8-) can be transferred to adult recipients
(reviewed by Scollay et al., 1988; Wu et al., 1991).
Thus, it is unclear as to why a secondary transfer
reveals the rapid loss of TSC. It is difficult to
accurately measure the number of donor cells trans-
ferred into the secondary recipient lobe. By injecting
up to 106 cells into the lobe of the primary recipient,
and up to 5 x 106 cells into the lobe of the secondary
recipient, by any reasonable calculation, we expect
to be still transferring in excess of 100,000 donor
cells after 96 hr. Using day-13-14 fetal thymocytes
as a source of TSC, we have been unable to see
adult lobe repopulation. Up to 5 x l0s day-13 and
I x 106 day-14 fetal thymocytes were injected I.T.
and recipient mice were examined between day 16
and day 21 after injection. This suggests a very rapid
commitment by the fetal liver-derived stem cells
within the fetal thymic lobes, although Guidos et al.
(1989) have reported a wave of thymic repopulation
after I.T. injection of 1-3x10s CD4-/CD8- fetal
thymocytes. It is possible that the inability to adop-
tively transfer TSC may reect pressure to reform the
thymic environment damaged by irradiation. The
possibility that stem-cell activity cannot be trans-
ferred because the cells have exited the thymus to
traffic through the bone marrow, before reseeding in
the thymus, can be discounted, as donor-derived
Thy-1
/ cells are only rarely detected in the nonin-
jected lobe. Sublethal irradiation of adult mice re-
sults in the loss of greater than 95% of thymocytes
over 3 days and essentially collapses the steady-
state microenvironments within the thymus (Takada
et al., 1969; reviewed by Anderson and Warner,
1976). The fact that injection of normal adult thy-
mocytes into a thymus of an irradiated recipient
does not immediately restore the integrity of the
thymus implies that there is a preciseness to thymic
structure that depends on clonal development of
recent stem-cell immigrants (Scollay et al., 1988).
The rapid loss of reconstitution potential of TSC
(Fig. 3) reinforces this. The I.T. injection of thymo-
cytes already committed to a temporal sequence of
events associated with maturation may be successful
only if by chance cells lodge in an appropriate
existing microenvironment or the thymocytes are
immature enough to retain reconstitution properties.
SLF induced significant proliferation of fetal liver
over 7 days in culture (Fig. 4), whereas IL-1,8, IL-3,
IL-6, IL-7, and LIF maintained the viability of only
a fraction of the cells. The inability of SLF grown
fetal liver cells to reconstitute the thymus suggests
that either the TSC have died in this culture system
or they have been induced to differentiate and
commit to a certain lineage, thus losing their TSC
activity. IL-1]/, IL-3, IL-6, and LIF failed to produce
significant proliferation over 7 days; however, these
cytokines all established conditions that were fa-
vourable for the maintenance of viable TSC. These
TSC may express receptors for all these cytokines
(Dexter et al., 1990), or these factors may all act
through an intermediate cell, resulting in the pro-
duction of a further cytokine(s). The addition of SLF
with any of these cytokines resulted in enhanced
proliferation of the fetal liver cells. These cultures
were also able to maintain the TSC in culture.
Cultures supplemented with IL-7 or SLF, or the two
in combination, failed to support the TSC. Growth
of bone marrow cells with IL-7 alone or in combi-
nation with SLF may favor early B-cell development
(Namen et al., 1988; McNiece et al., 1991). The
combination of SLF and IL-3 has been shown to
cause proliferation of stem cells purified from adult
murine bone marrow as detected by a net increase
in day-14 CFU-S (de Vries et al., 1991). However,254 McKENNA et al.
this combination did not bring about a net increase
in TSC in day-12 fetal liver, though it is quite
possible that there had been some stem-cell self-
renewal that was counteracted by some stem-cell
death; see Fig. 2(B). This may reflect the influence of
cytokines produced by the range of cells other than
stem cells present in fetal liver. Efforts are underway
now to purify the TSC cells in fetal liver to follow
the effect SLF and IL-3 have on a purified popula-
tion.
MATERIALS AND METHODS
Mice
C57BL/KATHY (Thyl.1) and C57BL/10J (Thyl.2)
mice were bred at the School of Medicine, Auckland
University, New Zealand. Mice were mated over-
night and fetal liver isolated from day-l 1-13 em-
bryos.
Cell Suspensions
Freshly isolated fetal livers and adult thymuses were
forced through a fine sieve to prepare single-cell
suspensions. In each case, numbers of viable cells
were estimated using trypan blue exclusion.
Flow Cytometry
Flow cytometry was performed on a fluorescence-
activated cell sorter (FACS 440, Becton Dickinson,
Mountain View, CA) equipped with dual 2- and 5-
watt argon lasers. Either laser was used at 200-mw
output using the 488-nm line. For each treatment,
I x 104 viable cells were analyzed. All data were
collected and analyzed on a MicroVAX computer
using Consort 40 (Becton Dickinson) software.
Monoclonal Antibodies
Staining for detection of Thyl.1 antigen was per-
formed using saturating amounts of anit-Thyl.1
antibody, clone 22.1.D 1, for 30 min at 4C, followed
by a fluoresceinated anti-mouse IgM (Tago, Auck-
land, New Zealand). Staining for detection of
Thyl.2 antigen was performed using anti-Thyl.2
antibody directly conjugated to FITC (Becton Dick-
enson). The media used for washing the cells com-
prised PBS with 2% FCS (Life Technologies,
Auckland, New Zealand) and 0.01% sodium azide.
Propidium iodide was included in the final wash at
10 mg/ml, and used to exclude dead cells.
Intrathymic Injections
C57BL/Thy1.1 mice were used as recipients at 6-10
weeks of age. These mice were sublethally irradi-
ated (750 rads) using a Cobalt-60 source. Three
hours later, mice were anesthetized using a combi-
nation of Ketalar (Parke-Davis, Caringbah, N.S.W.,
Australia) at 188/g/gm body weight and Rompun
(Bayer, Auckland, N.Z.) at 6.4/g/gm body weight,
injected intramuscularly. An incision was made in
the thoracic region, exposing the sternum, and the
anterior third of the sternum was bisected. Cell
suspensions were then injected using a Hamilton
syringe (Reno, Nv), equipped with a 30-gauge nee-
dle (Smith and Nephew MPL, Chicago, II), in 10-/1
volumes into one thymic lobe. The incision was
closed with Michel clips. All donor cells were de-
rived from day-11-13 unfractionated fetal liver
from C57BL/Thy1.2 mice. At designated times after
transfer of the cells, the mice were sacrificed and
thymus lobes harvested, single-cell suspension were
prepared, and expression of the surface markers
Thyl. 1 and Thyl.2 was examined.
Fetal Liver Cell Culture
Single-cell suspensions of C57BL/Thy1.2 day-12
fetal liver were prepared. For each culture 5 x 10s
viable cells as determined by trypan blue exclusion
were placed in 1 ml of DMEM containing 10% fetal
calf serum, additional amino acids, and 5 x 10
-5 M
2-mercaptoethanol. The designated cytokines (Im-
munex, Seattle, WA) were addded at 20-30 ng/ml.
After 5 days in culture, the medium was replaced.
After 7 days, the cells were harvested from the wells
and counted using trypan blue to determine cell
viability.
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